Searched for
LUNG CANCER DRUG
US stocks: Summit shares drop after US FDA declines to approve lung cancer drugSummit Therapeutics faced a notable decline in share value following the FDA's ruling on ivonescimab, which revealed insufficient overall s...
Cancer drug prices to fall by up to 96% from November 9; consumers set to save Rs 3,502 crore annuallyStarting November 9, consumers in India will benefit from significantly reduced prices on 137 anti-cancer drugs. The government has capped ...
Short-term headwinds, yes; owning the ecosystem is better: 20 healthcare stocks with downside risk of 23% to upside potential of 41%The healthcare sector is under scrutiny. The issue is pricing: What medicines cost and on what hospitals and the rest of the health ecosyst...
Cancer drug price cuts leave costly brands untouchedPrices of several anti-cancer drugs are set to fall significantly starting November 9, offering some financial relief. However, the prices ...
Cipla sets sights on first-wave gains from rollout of Keytruda BiosimilarCipla has partnered with Qilu Pharmaceutical to commercialize a biosimilar of Keytruda, which is a major cancer treatment. The patent for t...
Rs 1 lakh to Rs 30,000: Cancer immunotherapy gets cheaper, but will patients get the price benefit?Cheaper nivolumab biosimilars are expanding access to cancer immunotherapy in India, with one Mumbai oncologist reporting a more than 50% r...
Pope Leo cancer diagnosis: What is lung adenocarcinoma, symptoms, treatments & who are at riskPope Leo has been found to have lung adenocarcinoma, which is among the most common types of lung cancer. He recently had surgery to excise...
Zydus moves closer to US market for Keytruda biosimilar as FDA accepts applicationZydus Lifesciences has received acceptance for its application regarding the biosimilar of Keytruda, which is a major cancer drug. The USFD...
Why is Summit Therapeutics share price up today by 22%?Summit Therapeutics share price is up today by 22% after biopharma firm announced AstraZeneca would invest $2 billion in it. British drugma...
Benjamin Satterley death: From Bray Wyatt to Andre the Giant to Chyna, WWE stars who died before the age of 50Benjamin Satterley, a talented professional wrestler from England, passed away at the age of 40. All Elite Wrestling confirmed the sad news...
India needs five-year policy to make precision cancer care afforable, says expertIndia needs a five-year roadmap to expand access to genomic testing and targeted cancer therapies for lower-income patients, oncologist Dr ...
Dr. Reddy's launches nivolumab biosimilar in IndiaDr Reddy's Laboratories has taken a significant step in cancer care with the introduction of NIVORZ, a biosimilar of nivolumab. Designed to...
Glenmark initiates multi-nation Phase 3 clinical trial for lung cancer drugGlenmark Pharmaceuticals has commenced a Phase 3 clinical trial across multiple countries, including India, Russia, Brazil, and Mexico, for...
You thought only DeepSeek routed American titans? Wait, here's a little-known Chinese biotech company whose lung cancer drug could rattle big pharma; here's all about itChinese biotech company Akeso developed a lung cancer drug Ivonescimab, which outperformed Merck's Keytruda in trials. This breakthrough si...
Bristol Myers to buy Mirati for $4.8 billionThe purchase will give a boost to Bristol as patent expirations weigh on sales of its oncology medicines. The company had to slash its reve...
- New method to make lung cancer drug trials more successful
Melbourne, June 14 (IANS) Australian researchers have developed a new method for finding participants in clinical trials of lung cancer dru...
Good cancer drug data helps AstraZeneca in Pfizer fightBritain's second-biggest drugmaker has rejected a $106 billion approach from its US rival Pfizer, arguing that it has a bright future.
Cadila Pharmaceuticals launches lung cancer drugThe company claims that the drug Mycidac-C is for the first time in the world an affordable, unique and innovative drug for the treatment o...
New drug could potentially treat lung cancerThe drug has shown early potential as an effective treatment for non-small cell lung cancer, the leading cause of cancer death worldwide.
- Pfizer warns of lung cancer link with inhaled insulin
US drugmakers Pfizer Inc and Nektar Therapeutics warned of cases of lung cancer in clinical trials of their inhaled insulin Exubera.